Preventive Medicine Doctors in Waukesha, WI Accepting Medicare

7 Preventive Medicine doctors found. Showing 1 - 7

Sarita Makhija, M.D. Preventive Medicine - Occupational Medicine Medicare: Accepting Medicare Assignments Practice Location: N14w23900 Stone Ridge Dr, Prohealth Care Medical Associates Inc, Waukesha, WI 53188 Phone: 262-574-8000

Christopher J Kolimas, MD Preventive Medicine - Occupational Medicine Medicare: Accepting Medicare Assignments Practice Location: 20611 Watertown Rd Ste J, Waukesha, WI 53186 Phone: 262-928-5900

Dr. Karen Ronquillo, M.S., M.D. Preventive Medicine - Clinical Informatics Medicare: Medicare Enrolled Practice Location: 20611 Watertown Rd Ste C, Waukesha, WI 53186 Phone: 262-333-3173    Fax: 262-333-3173

Joseph Michael Zompa, M.D. Preventive Medicine - Preventive Medicine/Occupational Environmental Medicine Medicare: Not Enrolled in Medicare Practice Location: 3000 N Grandview Blvd, W-685, Waukesha, WI 53188 Phone: 262-544-3600    Fax: 262-544-3091

Kim Krystal Koike, OTR Preventive Medicine - Preventive Medicine/Occupational Environmental Medicine Medicare: Medicare Enrolled Practice Location: 3712 Fiddlers Creek Dr., Waukesha, WI 53188 Phone: 314-640-4724

Dr. Sandra G Amadon, M.D. Preventive Medicine - Occupational Medicine Medicare: Accepting Medicare Assignments Practice Location: 240 Maple Ave, Prohealth Care Medical Associates Inc., Waukesha, WI 53149 Phone: 262-928-1900

Jean Deuster, M.D. Preventive Medicine - Preventive Medicine/Occupational Environmental Medicine Medicare: Not Enrolled in Medicare Practice Location: 20611 Watertown Rd Ste J, Waukesha, WI 53186 Phone: 262-928-5900

News Archive

Cantel Medical's fiscal 2010 second-quarter net income up 29%

CANTEL MEDICAL CORP. reported a 29% increase in net income to $4,876,000, or $0.29 per diluted share, on a 6.7% increase in sales to $66,587,000 for the second quarter ended January 31, 2010. This compares with net income of $3,774,000, or $0.23 per diluted share, on sales of $62,420,000 for the second quarter ended January 31, 2009.

Gastroenterologists select efficacy over safety, tolerability when prescribing new drug for Crohn's disease

Decision Resources Group finds that, when asked to indicate the relative importance of product attributes when prescribing a new drug for Crohn's disease (CD), the highest percentages of surveyed gastroenterologists in the United States and Europe selected efficacy over safety and tolerability or delivery.

Data finds low risk of serious complications in 2009 H1N1 infection

An analysis of data from influenza cases in Wisconsin indicates individuals with 2009 H1N1 infections were younger than those with H3N2 (2007-2008), and that the risk of most serious complications was not higher in adults or children with 2009 H1N1 compared with recent seasonal strains, according to a study in the September 8 issue of JAMA.

Debate over benefits and privacy concerns in the proposed Australian e-health scheme

There has been a move towards complete computerization of health and related information in the Australian Government's e-health scheme that will be set up in the next two years. This scheme is purported to cost $467 million of taxpayers' money. The plan has been criticized because of the fear that all test results; prescriptions etc. will then be available on a national database and accessible over the internet.

Synta initiates three multicenter trials to evaluate ganetespib with chemotherapy for AML and MDS

Synta Pharmaceuticals Corp. today announced the initiation of three multicenter, randomized trials supported by the Leukemia & Lymphoma Research Fund and Cancer Research UK, evaluating ganetespib in combination with chemotherapy in first-line treatment of patients with AML and high risk MDS.

Read more Medical News

› Verified 5 days ago